Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2014

01-04-2014 | Review Article

A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health

Authors: Tom E. Richardson, Claire L. O’Reilly, Timothy F. Chen

Published in: International Journal of Clinical Pharmacy | Issue 2/2014

Login to get access

Abstract

Background The importance of pharmacists in mental healthcare is starting to be recognised around the world. However few studies have focused on the evidence supporting pharmacist involvement in the inpatient mental healthcare setting. Aim Evaluate types of outcomes achieved and level of evidence supporting clinical pharmacy services in inpatient mental health settings. Methods Medline, PyscINFO and International Pharmaceutical Abstracts databases were searched from January 1990 to March 31 2013. Studies were included if in an inpatient setting, published in English, and reported an intervention provided by a pharmacist or involving a pharmacist with a pivotal role in an intervention team. Data were extracted according to sample population and size, study design and outline, country, role of the pharmacist in the study, and the main results of the study. The level of evidence for each study was assessed using Australia’s National Health and Medical Research Council’s hierarchy of clinical evidence and results were categorised as having economic, clinical and/or humanistic outcomes. Results Eighteen articles met the inclusion criteria. A range of pharmaceutical services provided by pharmacists in inpatient mental healthcare were identified. These services highlight the role of pharmacists as reviewers of medication charts, laboratory results and medication prescribing and as educators of patients and other health care professionals. Six studies included a control or comparison group and had pre and post intervention measures. These comprised of three randomised control trials, one historical control study and two case series post and pre-post tests, corresponding to evidence levels of II, III-3 and IV respectively. Seven studies reported clinical outcomes, two economical and one humanistic outcomes. One study reported both clinical and economical outcomes. Seven studies focused on impact evaluation measures. Conclusions Pharmacists provide a variety of services and play a significant role in inpatient mental healthcare. However, the level of evidence supporting these services is limited and the type of outcomes achieved is narrow.
Literature
1.
go back to reference Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J, et al. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psychiatr Soc. 2009;18(1):23–33.CrossRef Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J, et al. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psychiatr Soc. 2009;18(1):23–33.CrossRef
3.
go back to reference Paulose-Ram R, Safran MA, Jonas BS, Gu Q, Orwig D. Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiol Drug Saf. 2007;16(5):560–70.PubMedCrossRef Paulose-Ram R, Safran MA, Jonas BS, Gu Q, Orwig D. Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiol Drug Saf. 2007;16(5):560–70.PubMedCrossRef
4.
go back to reference Insel TR. Assessing the economic costs of serious mental illness. Am J Psychiatry. 2008;165(6):663–5.PubMedCrossRef Insel TR. Assessing the economic costs of serious mental illness. Am J Psychiatry. 2008;165(6):663–5.PubMedCrossRef
5.
go back to reference Pande S, Hiller JE, Nkansah N, Bero L. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database Syst Rev. 2013;(2). Pande S, Hiller JE, Nkansah N, Bero L. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database Syst Rev. 2013;(2).
7.
go back to reference Castelino RL, Bajorek BV, Chen TF. Retrospective evaluation of home medicines review by pharmacists in older Australian patients using the medication appropriateness index. Ann Pharmacother. 2010;44(12):1922–9.PubMedCrossRef Castelino RL, Bajorek BV, Chen TF. Retrospective evaluation of home medicines review by pharmacists in older Australian patients using the medication appropriateness index. Ann Pharmacother. 2010;44(12):1922–9.PubMedCrossRef
8.
go back to reference Ayorinde AA, Porteous T, Sharma P. Screening for major diseases in community pharmacies: a systematic review. Int J Pharm Pract. Epub 20 May 2013. Ayorinde AA, Porteous T, Sharma P. Screening for major diseases in community pharmacies: a systematic review. Int J Pharm Pract. Epub 20 May 2013.
9.
go back to reference Tett S, Higgins G, Armour C. Impact of pharmacist interventions on medication management by the elderly: a review of the literature. Ann Pharmacother. 1993;27(1):80–6.PubMed Tett S, Higgins G, Armour C. Impact of pharmacist interventions on medication management by the elderly: a review of the literature. Ann Pharmacother. 1993;27(1):80–6.PubMed
10.
go back to reference Kane S, Weber R, Dasta J. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29(5):691–8.PubMed Kane S, Weber R, Dasta J. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29(5):691–8.PubMed
11.
go back to reference Singhal P, Raisch D, Gupchup G. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother. 1999;33(12):1336–55.PubMedCrossRef Singhal P, Raisch D, Gupchup G. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother. 1999;33(12):1336–55.PubMedCrossRef
12.
go back to reference Pickard AS, Hung S-Y. An update on evidence of clinical pharmacy services’ impact on health-related quality of life. Ann Pharmacother. 2006;40(9):1623–34.PubMedCrossRef Pickard AS, Hung S-Y. An update on evidence of clinical pharmacy services’ impact on health-related quality of life. Ann Pharmacother. 2006;40(9):1623–34.PubMedCrossRef
13.
go back to reference Rubio-Valera M, Serrano-Blanco A, Magdalena-Belio J, Fernandez A, Garcia-Campayo J, Pujol MM, et al. Effectiveness of pharmacist care in the improvement of adherence to antidepressants: a systematic review and meta-analysis. Ann Pharmacother. 2011;45(1):39–48.PubMedCrossRef Rubio-Valera M, Serrano-Blanco A, Magdalena-Belio J, Fernandez A, Garcia-Campayo J, Pujol MM, et al. Effectiveness of pharmacist care in the improvement of adherence to antidepressants: a systematic review and meta-analysis. Ann Pharmacother. 2011;45(1):39–48.PubMedCrossRef
19.
go back to reference SHPA Committee of Specialty Practice in Mental Health Pharmacy. Standards of practice for mental health pharmacy. J Pharm Pract Res. 2012;42(2):142–5. SHPA Committee of Specialty Practice in Mental Health Pharmacy. Standards of practice for mental health pharmacy. J Pharm Pract Res. 2012;42(2):142–5.
20.
go back to reference Jenkins MH, Bond CA. The impact of clinical pharmacists on psychiatric patients. Pharmacotherapy. 1996;16(4):708–14.PubMed Jenkins MH, Bond CA. The impact of clinical pharmacists on psychiatric patients. Pharmacotherapy. 1996;16(4):708–14.PubMed
21.
go back to reference Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy. 2003;23(12):1634–44.PubMedCrossRef Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy. 2003;23(12):1634–44.PubMedCrossRef
23.
go back to reference National Institute for Health and Clinical Excellence. The guidelines manual. London: National Institute for Health and Clinical Excellence; 2007. National Institute for Health and Clinical Excellence. The guidelines manual. London: National Institute for Health and Clinical Excellence; 2007.
24.
go back to reference Khan K, Ter Riet G, Glanville J, Sowden A, Kleijnen J. Undertaking systematic reviews of research on effectiveness. CRD’s guidance for those carrying out or commissioning reviews. York: University of York; 2001. Khan K, Ter Riet G, Glanville J, Sowden A, Kleijnen J. Undertaking systematic reviews of research on effectiveness. CRD’s guidance for those carrying out or commissioning reviews. York: University of York; 2001.
25.
go back to reference Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al. Oxford centre for evidence-based medicine levels of evidence. Oxford: Centre for Evidence-Based Medicine; 2001. Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al. Oxford centre for evidence-based medicine levels of evidence. Oxford: Centre for Evidence-Based Medicine; 2001.
26.
go back to reference Gunter MJ. The role of the ECHO model in outcomes research and clinical practice improvement. Am J Manag Care. 1999;5(4 Suppl):S217–24.PubMed Gunter MJ. The role of the ECHO model in outcomes research and clinical practice improvement. Am J Manag Care. 1999;5(4 Suppl):S217–24.PubMed
27.
go back to reference Campbell AR, Nelson LA, Elliott E, Hieber R, Sommi RW. Analysis of cost avoidance from pharmacy students’ clinical interventions at a psychiatric hospital. Am J Pharm Educ. 2011;75(1). Article 8. Campbell AR, Nelson LA, Elliott E, Hieber R, Sommi RW. Analysis of cost avoidance from pharmacy students’ clinical interventions at a psychiatric hospital. Am J Pharm Educ. 2011;75(1). Article 8.
28.
go back to reference Canales PL, Dorson PG, Crismon ML. Outcomes assessment of clinical pharmacy services in a psychiatric inpatient setting. Am J Health Syst Pharm. 2001;58(14):1309–16.PubMed Canales PL, Dorson PG, Crismon ML. Outcomes assessment of clinical pharmacy services in a psychiatric inpatient setting. Am J Health Syst Pharm. 2001;58(14):1309–16.PubMed
29.
go back to reference Dolder C, Szymanski B, Wooton T, McKinsey J. Pharmacist interventions in an inpatient geriatric psychiatry unit. Am J Health Syst Pharm. 2008;65(19):1795–6.PubMedCrossRef Dolder C, Szymanski B, Wooton T, McKinsey J. Pharmacist interventions in an inpatient geriatric psychiatry unit. Am J Health Syst Pharm. 2008;65(19):1795–6.PubMedCrossRef
30.
go back to reference Goad JD, Ezell JR. Drug-use evaluation programs for psychotropic medications. Am J Hosp Pharm. 1990;47(1):132–6.PubMed Goad JD, Ezell JR. Drug-use evaluation programs for psychotropic medications. Am J Hosp Pharm. 1990;47(1):132–6.PubMed
31.
go back to reference Marino J, Caballero J, Llosent M, Hinkes R. Differences in pharmacy interventions at a psychiatric hospital: comparison of staff pharmacists, pharmacy faculty, and student pharmacists. Hosp Pharm. 2010;45(4):314–9.CrossRef Marino J, Caballero J, Llosent M, Hinkes R. Differences in pharmacy interventions at a psychiatric hospital: comparison of staff pharmacists, pharmacy faculty, and student pharmacists. Hosp Pharm. 2010;45(4):314–9.CrossRef
32.
go back to reference McKee J, Cleary S. High-risk, high-alert medication management practices in a regional state psychiatric facility. Hosp Pharm. 2007;42(4):323–30.CrossRef McKee J, Cleary S. High-risk, high-alert medication management practices in a regional state psychiatric facility. Hosp Pharm. 2007;42(4):323–30.CrossRef
33.
go back to reference Morton WA, Mendenhall AR, Windsor PG, Lydiard B. Clinical psychopharmacy consultations: acceptance of recommendations on an adult inpatient psychiatric unit. Hosp Pharm. 1995;30(9):786–90.PubMed Morton WA, Mendenhall AR, Windsor PG, Lydiard B. Clinical psychopharmacy consultations: acceptance of recommendations on an adult inpatient psychiatric unit. Hosp Pharm. 1995;30(9):786–90.PubMed
34.
go back to reference Stanislav SW, Barker K, Crismon ML, Childs A. Effect of a clinical psychopharmacy consultation service on patient outcomes. Am J Hosp Pharm. 1994;51(6):778–81.PubMed Stanislav SW, Barker K, Crismon ML, Childs A. Effect of a clinical psychopharmacy consultation service on patient outcomes. Am J Hosp Pharm. 1994;51(6):778–81.PubMed
35.
go back to reference Suehs BT, Mican LM, Campbell AH. Retrospective evaluation of an inpatient psychiatric pharmacist consultation service. J Am Pharm Assoc. 2011;51(5):599–604.CrossRef Suehs BT, Mican LM, Campbell AH. Retrospective evaluation of an inpatient psychiatric pharmacist consultation service. J Am Pharm Assoc. 2011;51(5):599–604.CrossRef
36.
go back to reference Stoner SC, Worrel JA, Jones MT, Farrar CA, Ramlatchman LV. Pharmacist-designed and -implemented pharmaceutical care plan for antipsychotic-induced movement disorders. Pharmacotherapy. 2000;20(5):583–8.PubMedCrossRef Stoner SC, Worrel JA, Jones MT, Farrar CA, Ramlatchman LV. Pharmacist-designed and -implemented pharmaceutical care plan for antipsychotic-induced movement disorders. Pharmacotherapy. 2000;20(5):583–8.PubMedCrossRef
37.
go back to reference Al-Saffar N, Deshmukh AA, Carter P, Adib SM. Effect of information leaflets and counselling on antidepressant adherence: open randomised controlled trial in a psychiatric hospital in Kuwait. Int J Pharm Pract. 2005;13(2):123–31.CrossRef Al-Saffar N, Deshmukh AA, Carter P, Adib SM. Effect of information leaflets and counselling on antidepressant adherence: open randomised controlled trial in a psychiatric hospital in Kuwait. Int J Pharm Pract. 2005;13(2):123–31.CrossRef
38.
go back to reference Hazra M, Uchida H, Sproule B, Remington G, Suzuki T, Mamo DC. Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia. Psychiatry Clin Neurosci. 2011;65(7):676–8.PubMedCrossRef Hazra M, Uchida H, Sproule B, Remington G, Suzuki T, Mamo DC. Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia. Psychiatry Clin Neurosci. 2011;65(7):676–8.PubMedCrossRef
39.
go back to reference Thompson A, Sullivan SA, Barley M, Strange SO, Moore L, Rogers P, et al. The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards—a cluster randomized controlled trial. Psychol Med. 2008;38(05):705–15.PubMedCrossRef Thompson A, Sullivan SA, Barley M, Strange SO, Moore L, Rogers P, et al. The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards—a cluster randomized controlled trial. Psychol Med. 2008;38(05):705–15.PubMedCrossRef
40.
go back to reference Ved P, Coupe T. Improving prescription quality in an in-patient mental health unit: three cycles of clinical audit. Psychiatr Bull. 2007;31(8):293–4.CrossRef Ved P, Coupe T. Improving prescription quality in an in-patient mental health unit: three cycles of clinical audit. Psychiatr Bull. 2007;31(8):293–4.CrossRef
41.
go back to reference Virani A, Crown N. The impact of a clinical pharmacist on patient and economic outcomes in a child and adolescent mental health unit. Can J Hosp Pharm. 2003;56(3):158–62. Virani A, Crown N. The impact of a clinical pharmacist on patient and economic outcomes in a child and adolescent mental health unit. Can J Hosp Pharm. 2003;56(3):158–62.
42.
go back to reference Alderman CP. A prospective analysis of clinical pharmacy interventions on an acute psychiatric inpatient unit. J Clin Pharm Ther. 1997;22(1):27–31.PubMedCrossRef Alderman CP. A prospective analysis of clinical pharmacy interventions on an acute psychiatric inpatient unit. J Clin Pharm Ther. 1997;22(1):27–31.PubMedCrossRef
43.
go back to reference Shaw H, Mackie CA, Sharkie I. Evaluation of effect of pharmacy discharge planning on medication problems experienced by discharged acute admission mental health patients. Int J Pharm Pract. 2000;8(2):144–53.CrossRef Shaw H, Mackie CA, Sharkie I. Evaluation of effect of pharmacy discharge planning on medication problems experienced by discharged acute admission mental health patients. Int J Pharm Pract. 2000;8(2):144–53.CrossRef
44.
go back to reference Dorevitch A, Perl E. The impact of clinical pharmacy intervention in a psychiatric inpatient hospital. J Clin Pharm Ther. 1996;21:45–8.PubMedCrossRef Dorevitch A, Perl E. The impact of clinical pharmacy intervention in a psychiatric inpatient hospital. J Clin Pharm Ther. 1996;21:45–8.PubMedCrossRef
45.
go back to reference Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342(25):1887–92.PubMedCentralPubMedCrossRef Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342(25):1887–92.PubMedCentralPubMedCrossRef
46.
go back to reference Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–64.PubMedCrossRef Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–64.PubMedCrossRef
Metadata
Title
A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health
Authors
Tom E. Richardson
Claire L. O’Reilly
Timothy F. Chen
Publication date
01-04-2014
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 2/2014
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-013-9900-y

Other articles of this Issue 2/2014

International Journal of Clinical Pharmacy 2/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.